These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 33911382)

  • 21. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
    Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
    Dos Passos GR; Oliveira LM; da Costa BK; Apostolos-Pereira SL; Callegaro D; Fujihara K; Sato DK
    Front Neurol; 2018; 9():217. PubMed ID: 29670575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.
    Netravathi M; Holla VV; Nalini A; Yadav R; Vengalil S; Oommen AT; Reshma SS; Kamble N; Thomas PT; Maya B; Pal PK; Mahadevan A
    J Neurol; 2021 Apr; 268(4):1419-1433. PubMed ID: 33188477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
    Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
    JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
    Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K
    Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
    Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R
    Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report.
    Olbert E; Brunner C; Alhani N; Našel C; Struhal W
    eNeurologicalSci; 2022 Dec; 29():100432. PubMed ID: 36388768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes.
    Lana-Peixoto MA; Talim N
    Biomedicines; 2019 Jun; 7(2):. PubMed ID: 31212763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
    Sepúlveda M; Armangue T; Martinez-Hernandez E; Arrambide G; Sola-Valls N; Sabater L; Téllez N; Midaglia L; Ariño H; Peschl P; Reindl M; Rovira A; Montalban X; Blanco Y; Dalmau J; Graus F; Saiz A
    J Neurol; 2016 Jul; 263(7):1349-60. PubMed ID: 27147513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases.
    Guzmán J; Vera F; Soler B; Uribe-San-Martin R; García L; Del-Canto A; Schlatter A; Salazar M; Molt F; Ramirez K; Marín J; Pelayo C; Cruz JP; Bravo-Grau S; Cárcamo C; Ciampi E
    Mult Scler Relat Disord; 2023 Jan; 69():104442. PubMed ID: 36521387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
    Akaishi T; Sato DK; Takahashi T; Nakashima I
    Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination.
    Zhou J; Lu X; Zhang Y; Ji T; Jin Y; Xu M; Bao X; Zhang Y; Xiong H; Chang X; Jiang Y; Wu Y
    Mult Scler Relat Disord; 2019 Feb; 28():4-10. PubMed ID: 30529926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder.
    Salama S; Pardo S; Levy M
    Mult Scler Relat Disord; 2019 May; 30():231-235. PubMed ID: 30825703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management.
    Ambrosius W; Michalak S; Kozubski W; Kalinowska A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India.
    Pandit L; Sato DK; Mustafa S; Takahashi T; D'Cunha A; Malli C; Sudhir A; Fujihara K
    Mult Scler J Exp Transl Clin; 2016; 2():2055217316675634. PubMed ID: 28607742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.